Product Information
CELECOXIB 50 MG CAPSULE is a generic product labeled by Cranbury Pharmaceuticals, LLC, priced at $0.0914 per EA under NDC 27808029501. Its NADAC has been published 69 times since Jun 11, 2025.
FDA first approved this application on Jan 23, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Cranbury Pharmaceuticals, LLCNDC
27808029501
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CELECOXIBApproval Type
Generic (ANDA)
FDA Application
ANDA210071FDA Approved
1/23/2018
TE Code
AB
On Market Since
12/1/2024
Pharmacological Classes
Price Statistics
The NADAC for CELECOXIB 50 MG CAPSULE has been published 69 times since Jun 11, 2025, and over the history we have for it it has risen 12.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0914 per EA |
|---|---|
| All-time high | $0.1073 (May 13, 2026) |
| All-time low | $0.0737 (Jul 23, 2025) |
| 52-week high | $0.1073 |
| 52-week low | $0.0817 |
| Median price | $0.0883 |
| Average price | $0.0908 |
| Largest weekly change | -11.7% (Jun 17, 2026) |
| Weeks tracked | 69 |
| Tracking since | Jun 11, 2025 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cranbury Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Celecoxib market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CELECOXIB 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CELECOXIB 50 MG CAPSULE, manufactured by Cranbury Pharmaceuticals, LLC, is $0.0914 per EA (NDC 27808029501), effective Sep 30, 2026.
How has the price of CELECOXIB 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CELECOXIB 50 MG CAPSULE has risen 12.4%. It has been tracked across 69 weekly CMS publications since Jun 11, 2025.
What are the highest and lowest recorded NADAC prices for CELECOXIB 50 MG CAPSULE?
Since Jun 11, 2025, the NADAC for CELECOXIB 50 MG CAPSULE has ranged from a low of $0.0737 (Jul 23, 2025) to a high of $0.1073 (May 13, 2026), with a median of $0.0883 per EA.
Are there cheaper alternatives to CELECOXIB 50 MG CAPSULE?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CELECOXIB 50 MG CAPSULE, is $0.0883 per EA — about 3% below CELECOXIB 50 MG CAPSULE.
Who manufactures CELECOXIB 50 MG CAPSULE?
CELECOXIB 50 MG CAPSULE (NDC 27808029501) is labeled by Cranbury Pharmaceuticals, LLC, and CMS classifies it as a generic product.